Bristol-Myers Squibb to Present at Credit Suisse Healthcare Conference Business Wire NEW YORK -- November 07, 2012 Bristol-Myers Squibb Company (NYSE: BMY) will present at the 2012 Credit Suisse Healthcare Conference on Wednesday, November 14, 2012, in Phoenix. Douglas Manion, senior vice president, Development, Neuroscience, Virology and Japan, will make a formal presentation about the company at 1:30 p.m. MT (3:30 p.m. ET). Investors and the general public are invited to listen to a live webcast of the presentation at http://investor.bms.com. Materials related to the presentation will be available at the same website at the start of the live webcast. An archived edition of the presentation will be available later that day. About Bristol-Myers Squibb Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews. Contact: Bristol-Myers Squibb Company Media: Jennifer Fron Mauer, 609-252-6579 email@example.com or Investors: John Elicker, 609-252-4611 firstname.lastname@example.org
Bristol-Myers Squibb to Present at Credit Suisse Healthcare Conference
Press spacebar to pause and continue. Press esc to stop.